NCT00467324View on ClinicalTrials.gov

The Advance Trial. Tongue Advancement for Obstructive Sleep Apnea: An Evaluation of the Aspire Medical Advance System

NAUnknownINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2008

Conditions
Sleep Apnea, Obstructive
Interventions
DEVICE

Aspire Medical Advance System

The treatment includes a device that is surgically implanted in the tongue and lower jaw. The purpose of the implant is to prevent obstruction of the upper airway thereby improving breathing during sleep.

Trial Locations (4)

30342

Northside Hospital/Advanced Ear Nose & Throat Associates PC, Atlanta

45267

University of Cincinnati Medical Center, Cincinnati

46032

St. Vincent's Hospital, Indianapolis

53051

Medical College of Wisconsin, Milwaukee

Sponsors

Lead Sponsor

Aspire Medical
All Listed Sponsors
lead

Aspire Medical

INDUSTRY

NCT00467324 - The Advance Trial. Tongue Advancement for Obstructive Sleep Apnea: An Evaluation of the Aspire Medical Advance System | Biotech Hunter | Biotech Hunter